Table of Contents
ISRN Analytical Chemistry
Volume 2012, Article ID 617175, 12 pages
http://dx.doi.org/10.5402/2012/617175
Research Article

Utility of p-Chloranilic Acid and 2,3-Dichloro-5,6-dicyano-p-benzoquinone for the Spectrophotometric Determination of Rizatriptan Benzoate

Department of Chemistry, University of Mysore, Manasagangotri, Karnataka, Mysore 570006, India

Received 6 April 2012; Accepted 27 May 2012

Academic Editors: A. Bouklouze, A. Golcu, V. Maier, G. Ramis-Ramos, and A. Szemik-Hojniak

Copyright © 2012 Kudige N. Prashanth and Kanakapura Basavaiah. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. J. Goadsby, “Serotonin 5-HT1B/1D receptor agonists in migraine: comparative pharmacology and its therapeutic implications,” CNS Drugs, vol. 10, no. 4, pp. 271–286, 1998. View at Google Scholar · View at Scopus
  2. S. Gori, N. Morelli, G. Bellini et al., “Rizatriptan does not change cerebral blood flow velocity during migraine attacks,” Brain Research Bulletin, vol. 65, no. 4, pp. 297–300, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. A. D. Oldman, L. A. Smith, H. J. McQuay, and R. A. Moore, “Pharmacological treatments for acute migraine: quantitative systematic review,” Pain, vol. 97, no. 3, pp. 247–257, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. D. J. Williamson, S. L. Shepheard, R. G. Hill, and R. J. Hargreaves, “The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation,” European Journal of Pharmacology, vol. 328, no. 1, pp. 61–64, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. P. E. Mahuzier, B. J. Clark, A. J. Crumpton, and A. J. Kevin, “Quantitative microemulsion electrokinetic capillary chromatography analysis of formulated drug products,” Journal of Separation Sciences, vol. 24, no. 9, pp. 784–788, 2001. View at Google Scholar
  6. J. V. Shanmukha kumar, D. Ramachandran, V. S. Settaluri, L. A. Lakshmi, and F. C. Shechinah, “Validation of analytical procedures for determination of rizatriptan benzoate,” The Pharma Research, vol. 4, pp. 28–37, 2010. View at Google Scholar
  7. S. D. Gowry and K. M. Vamsi, “Visible spectrophotometric methods for the determination of rizatriptan in pure form and in pharmaceutical formulations,” Analytical Chemistry, vol. 3, pp. 4–6, 2007. View at Google Scholar
  8. K. N. Prashanth and K. Basavaiah, “Sensitive and selective methods for the determination of rizatriptanbenzoate in pharmaceuticals using N-bromosuccinimide and two dyes,” Journal of Saudi Chemical Society. In press.
  9. J. F. Guo, A. J. Zhang, L. Zhao et al., “Determination of rizatriptan in human plasma by liquid chromatographic-eletrospray tandem mass spectrometry: application to a pharmacokinetic study,” Biomedical Chromatography, vol. 20, no. 1, pp. 61–66, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Chen, H. Miao, M. Lin et al., “Development and validation of a selective and robust LC-MS/MS method for high-throughput quantifying rizatriptan in small plasma samples: application to a clinical pharmacokinetic study,” Journal of Chromatography B, vol. 844, no. 2, pp. 268–277, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. P. Qin, Y. G. Zou, M. Z. Liang, and Q. Yu, “Determination of rizatriptan in human plasma by RP-HPLC with fluorescence detection,” Yaowu Fenxi Zazhi, vol. 26, no. 1, pp. 7–9, 2006. View at Google Scholar
  12. J. Chen, X. Jiang, W. Jiang, N. Mei, X. Gao, and Q. Zhang, “Liquid chromatographic method for the determination of rizatriptan in human plasma,” Journal of Chromatography B, vol. 805, no. 1, pp. 169–173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Vishwanathan, M. G. Bartlett, and J. T. Stewart, “Determination of antimigraine compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/electrospray tandem mass spectrometry,” Rapid Communicatons in Mass Spectrometry, vol. 14, no. 3, pp. 168–172, 2000. View at Google Scholar
  14. K. Amol, R. Vivek, K. Alpana, D. M. Hassan, S. Maria, and L. Swaroop, “Spectrophotometric method for analysis of rizatriptan benzoate,” International Journal of Pharmaceutical Sciences, vol. 1, no. 2, pp. 307–309, 2009. View at Google Scholar
  15. A. S. Kumari, S. Subhasish, D. K. Kaushik, and M. M. Annapurna, “UV-spectroscopic methods for estimation of rizatriptan benzoate in pharmaceutical preparations,” International Journal of ChemTech Research, vol. 2, no. 1, pp. 653–659, 2010. View at Google Scholar · View at Scopus
  16. R. Vivek, K. Amol, K. Alpana, D. M. Hassan, and D. M. Maria, “Spectrophotometric estimation of rizatriptan benzoate,” Asian Journal of Research in Chemistry, vol. 3, no. 1, pp. 175–177, 2010. View at Google Scholar
  17. S. Altinoz, G. Ucar, and E. Yildiz, “Determination of rizatriptan in its tablet dosage forms by UV spectrophotometric and spectrofluorimetric methods,” Analytical Letters, vol. 35, no. 15, pp. 2471–2485, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. M. Annapurna, S. Sravya, and C. Vineesha, “New derivative spectrophotometric methods for the determination of rizatriptan benzoate in pharmaceutical dosage forms,” International Journal of Pharmaceutical Sciences Review and Research, vol. 13, no. 2, pp. 133–136, 2012. View at Google Scholar
  19. M. Zečević, B. Jocić, L. Živanović, and A. Protić, “Application of multicriteria methodology in the development of improved RP-LC-DAD for determination of rizatriptan and its degradation products,” Chromatographia, vol. 68, no. 11-12, pp. 911–918, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Jocić, M. Zečević, L. Živanović, and A. Ličanski, “A chemometrical approach to optimization and validation of an HPLC assay for rizatriptan and its impurities in tablets,” Analytical Letters, vol. 40, no. 12, pp. 2301–2316, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. P. V. Sagar, D. Kumar, and D. Suddhasattya, “Simultaneous estimation of rizatriptan, sumatriptan and zolmitriptan by RP-HPLC method in bulk,” Journal of Pharmacy Research, vol. 3, no. 12, pp. 2930–2933, 2010. View at Google Scholar
  22. K. N. Prashanth, K. Basavaiah, and K. B. Vinay, “Sensitive and selective spectrophotometric assay of rizatriptanbenzoate in pharmaceuticals using three sulphonphthalein dyes,” Arabian Journal of Chemistry. In press.
  23. J. V. Shanmukha Kumar, K. R. S. Prasad, D. Ramachandran, and V. S. Settaluri, “Development and validation of spectrophotometric methods for determination of maxalt (Rizatriptan Benzoate) in pure and pharmaceutical formulation,” IJPI’s Journal of Analytical Chemistry, vol. 1, pp. 1–5, 2011. View at Google Scholar
  24. I. E. Ramzia, G. M. Nashwah, and A. Heba, “Fluorimetric and colorimetric methods for the determination of some antimigraine drugs,” Journal of Chemical and Pharmaceutical Research, vol. 3, no. 4, pp. 304–314, 2011. View at Google Scholar · View at Scopus
  25. C. Saka, “Review of analytical methods for identification and determination of triptans,” Critical Reviews in Analytical Chemistry, vol. 39, no. 1, pp. 32–42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. R. S. Mulliken, “Structures of complexes formed by halogen molecules with aromatic and with oxygenated solvents,” Journal of the American Chemical Society, vol. 72, no. 1, pp. 600–608, 1950. View at Google Scholar · View at Scopus
  27. R. Foster, Organic Charge-Transfer Complexes, Academic Press, New York, NY, USA, 1969.
  28. E. Khaled, “Spectrophotometric determination of terfenadine in pharmaceutical preparations by charge-transfer reactions,” Talanta, vol. 75, no. 5, pp. 1167–1174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. X. Cijo, K. Basavaiah, S. A. M. Abdulrahman, and K. B. Vinay, “Spectrophotometric determination of repaglinide in tablets based on charge-transfer complexation reaction with chloranilic acid and dichloro-dicyano benzoquinone,” Chemical Industry & Chemical Engineering Quarterly, vol. 17, no. 4, pp. 469–476, 2011. View at Google Scholar
  30. K. B. Vinay, H. D. Revanasiddappa, M. S. Raghu, A. M. Sameer. Abdulrahman, and N. Rajendraprasad, “Spectrophotometric determination of mycophenolate mofetil as its charge-transfer complexes with two π-acceptors,” Journal of Analytical Methods in Chemistry, vol. 2012, Article ID 875942, 8 pages, 2012. View at Publisher · View at Google Scholar
  31. K. Basavaiah, K. Tharpa, and K. B. Vinay, “Spectrophotometric determination of isoxsuprine hydrochloride as base form in pharmaceutical formulation through charge transfer complexation,” Croatica Chemica Acta, vol. 83, no. 4, pp. 415–420, 2010. View at Google Scholar · View at Scopus
  32. M. Pandeeswaran and K. P. Elango, “Spectroscopic and kinetic studies on the interaction of ketoconazole and povidone drugs with DDQ,” Spectrochimica Acta A, vol. 69, no. 4, pp. 1082–1088, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Basavaiah and S. A. M. Abdulrahman, “Use of charge transfer complexation reaction for the spectrophotometric determination of bupropion in pharmaceuticals and spiked human urine,” Thai Journal of Pharmaceutical Sciences, vol. 34, no. 4, pp. 134–145, 2010. View at Google Scholar · View at Scopus
  34. M. E. Abdel-Hamid, M. Abdel-Salam, M. S. Mahrous, and M. M. Abdel-Khalek, “Utility of 2,3-dichloro-5,6-dicyano-p-benzoquinone in assay of codeine, emetine and pilocarpine,” Talanta, vol. 32, no. 10, pp. 1002–1004, 1985. View at Google Scholar · View at Scopus
  35. R. Nafisur and K. Mohammad, “Optimized and validated spectrophotometric methods for the determination of roxatidine acetate hydrochloride in drug formulations using 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and p-chloranilic acid,” Journal of Analytical Chemistry, vol. 60, no. 7, pp. 636–643, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. ICH Harmonised Tripartite Guideline, “Validation of analytical procedures: text and methodology Q2(R1),” in Proceedings of the International Conference on Hormonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Complementary Guideline on Methodology, London, UK, November 1996, Incorporated in November 2005.